0
Clinical Investigations: ASTHMA |

Comparison of High-Dose Inhaled Flunisolide to Systemic Corticosteroids in Severe Adult Asthma*

Mary Lee-Wong, MD; Francis M. Dayrit, MD; Anita R. Kohli, MD; Samuel Acquah, MD, FCCP; Paul H. Mayo, MD, FCCP
Author and Funding Information

*From the Divisions of Allergy/Immunology (Drs. Lee-Wong and Kohli) and Pulmonary/Critical Care Medicine (Drs. Mayo, Dayrit, and Acquah), Beth Israel Medical Center, Albert Einstein College of Medicine, New York, NY.

Correspondence to: Mary Lee-Wong, MD, Beth Israel Medical Center, 350 East 17th St, 18 BH22, New York, NY 10003



Chest. 2002;122(4):1208-1213. doi:10.1378/chest.122.4.1208
Text Size: A A A
Published online

Objective: To investigate whether, after 48 h of IV treatment with corticosteroids, the use of high-dose inhaled flunisolide is as effective as systemic corticosteroids in adults hospitalized for a severe asthma exacerbation.

Design: Randomized, double-blind, placebo-controlled study.

Setting: Inpatient, an urban teaching hospital medical ward; outpatient, asthma clinic affiliated with the hospital.

Participants: Forty patients aged 18 to 55 years with asthma exacerbation requiring hospitalization.

Interventions: Inhaled flunisolide via metered-dose inhaler (250 μg per activation) eight puffs bid compared to systemic corticosteroids alone, following eight doses of IV corticosteroids.

Measurements and results: Peak expiratory flow rate (PEFR), FEV1, and symptom scores were recorded on day 1 (at presentation to the emergency department) and day 7, at an outpatient follow-up visit. From day 1 to day 7, mean PEFR increased from 190 to 379 L/min in the flunisolide group, and from 207 to 347 L/min in the systemic corticosteroids group (p = 0.95; 95% confidence interval [CI], − 66.3, ∞). Mean FEV1 increased from 1.6 to 2.3 L in the flunisolide group, and from 1.4 to 2.1 L in the systemic corticosteroids group (p = 0.33; 95% CI, − 21.7, ∞). Changes in symptom scores were − 0.7 in the flunisolide group and − 0.9 in the systemic corticosteroids group (p = 0.39; 95% CI, − 0.4, ∞). Hospital readmission rates on day 7 were zero for both groups.

Conclusions: High-dose inhaled corticosteroids are as effective as systemic corticosteroids during a 7-day period following admission to the hospital for severe asthma.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Guidelines
Management of asthma.
Singapore Ministry of Health | 7/18/2008
Adapting your practice: treatment and recommendations for homeless patients with asthma.
National Health Care for the Homeless Council, Inc. | 6/13/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543